tradingkey.logo

Aligos Therapeutics Inc

ALGS

9.670USD

-0.320-3.20%
Close 09/19, 16:00ETQuotes delayed by 15 min
67.22MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
-9.05%965.00K
-68.46%311.00K
-76.54%629.00K
-60.82%1.27M
-84.59%1.06M
-63.79%986.00K
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
863.76%3.54M
167.14%4.11M
139.03%3.69M
182.53%2.57M
--367.00K
--1.54M
--1.54M
--910.00K
----
----
--0.00
--0.00
Revenue
-9.05%965.00K
-68.46%311.00K
-76.54%629.00K
-60.82%1.27M
-84.59%1.06M
-63.79%986.00K
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
863.76%3.54M
167.14%4.11M
139.03%3.69M
182.53%2.57M
--367.00K
--1.54M
--1.54M
--910.00K
----
----
--0.00
--0.00
Operating expenses
-28.91%19.53M
-15.10%19.55M
-40.95%16.99M
-3.65%21.40M
19.32%27.48M
-0.47%23.03M
9.76%28.78M
-3.66%22.21M
-4.40%23.03M
-39.31%23.14M
-31.57%26.22M
-33.38%23.05M
-22.58%24.09M
33.08%38.13M
11.75%38.31M
60.53%34.60M
46.26%31.11M
38.27%28.65M
--34.29M
--21.56M
--21.27M
--20.72M
R&D expenses
-33.76%13.98M
-11.39%14.50M
-27.97%16.03M
5.72%16.77M
25.73%21.10M
-9.75%16.37M
16.53%22.26M
-10.81%15.87M
1.64%16.78M
-42.75%18.14M
-33.21%19.10M
-36.76%17.79M
-32.76%16.51M
38.51%31.68M
1.84%28.60M
67.39%28.13M
42.96%24.55M
32.18%22.87M
--28.08M
--16.81M
--17.18M
--17.30M
Depreciation, depletion, and amortization
0.00%300.00K
-33.33%200.00K
-38.83%241.00K
-2.28%300.00K
-25.74%300.00K
-33.92%300.00K
-24.52%394.00K
-42.94%307.00K
-32.67%404.00K
-32.84%454.00K
-28.30%522.00K
-31.29%538.00K
-22.08%600.00K
-8.77%676.00K
-0.27%728.00K
10.59%783.00K
-19.71%770.00K
112.93%741.00K
--730.00K
--708.00K
--959.00K
--348.00K
Operating profit
29.71%-18.57M
12.71%-19.24M
37.30%-16.36M
-6.11%-20.13M
-63.65%-26.41M
-7.97%-22.05M
-15.06%-26.10M
-0.12%-18.97M
20.85%-16.14M
42.58%-20.42M
40.23%-22.68M
42.70%-18.95M
31.02%-20.39M
-28.18%-35.56M
-10.68%-37.95M
-53.40%-33.07M
-38.99%-29.57M
-33.87%-27.74M
---34.29M
---21.56M
---21.27M
---20.72M
Net non-operating interest income (expenses)
Non-operating interest income
24.14%396.00K
45.17%842.00K
-80.24%314.00K
-54.53%457.00K
-66.60%319.00K
-22.46%580.00K
109.91%1.59M
115.67%1.00M
350.47%955.00K
769.77%748.00K
1582.22%757.00K
2230.00%466.00K
190.41%212.00K
-18.10%86.00K
-83.39%45.00K
-91.45%20.00K
-80.48%73.00K
-77.56%105.00K
--271.00K
--234.00K
--374.00K
--468.00K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.00K
----
----
----
----
----
----
----
Special income (expenses)
--1.68M
--61.49M
-50432.00%-50.33M
----
----
----
--100.00K
---100.00K
---3.00M
---3.50M
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-97.41%811.00K
100.28%38.00K
-347.98%-15.74M
837.04%506.00K
20521.71%31.34M
-5364.96%-13.37M
-4093.18%-3.51M
129.67%54.00K
-50.00%152.00K
379.12%254.00K
-33.33%88.00K
-464.00%-182.00K
202.01%304.00K
-1616.67%-91.00K
170.97%132.00K
100.42%50.00K
-826.83%-298.00K
-97.32%6.00K
---186.00K
---11.97M
--41.00K
--224.00K
Income before tax
-398.63%-15.68M
223.80%43.13M
-194.12%-82.12M
-6.42%-19.17M
129.11%5.25M
-52.03%-34.84M
-27.87%-27.92M
3.49%-18.01M
9.27%-18.03M
35.56%-22.92M
42.19%-21.84M
43.44%-18.66M
33.28%-19.88M
-28.71%-35.56M
-10.44%-37.77M
0.90%-33.00M
-42.84%-29.79M
-37.94%-27.63M
---34.20M
---33.30M
---20.86M
---20.03M
Income tax
-2.12%185.00K
79.17%43.00K
190.00%27.00K
213.79%91.00K
-75.03%189.00K
-38.46%24.00K
-161.22%-30.00K
167.44%29.00K
1510.64%757.00K
-26.42%39.00K
184.48%49.00K
-134.13%-43.00K
67.86%47.00K
17.78%53.00K
-126.48%-58.00K
--126.00K
147.46%28.00K
--45.00K
--219.00K
--0.00
---59.00K
--0.00
Income after tax
-413.44%-15.86M
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Net income from continuous operations
-413.44%-15.86M
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Net income attributable to controlling interests
-413.44%-15.86M
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Net income attributable to common shareholders
-413.44%-15.86M
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
-38.17%-27.67M
---34.42M
---33.30M
---20.80M
---20.03M
Basic earnings per share
-289.49%-1.53
191.81%5.12
-20.51%-13.08
70.39%-3.07
107.44%0.81
58.27%-5.58
15.04%-10.85
4.75%-10.37
6.89%-10.87
36.14%-13.37
43.15%-12.77
44.26%-10.89
40.89%-11.67
-13.32%-20.94
4.43%-22.47
13.45%-19.53
-40.13%-19.75
-36.16%-18.48
---23.51
---22.57
---14.09
---13.57
Diluted earnings per share
-289.72%-1.53
62.14%-2.11
-20.51%-13.08
70.39%-3.07
107.43%0.81
58.27%-5.58
15.04%-10.85
4.75%-10.37
6.89%-10.87
36.14%-13.37
43.15%-12.77
44.26%-10.89
40.89%-11.67
-13.32%-20.94
4.43%-22.47
13.45%-19.53
-40.13%-19.75
-36.16%-18.48
---23.51
---22.57
---14.09
---13.57
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI